ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 61 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,463 | -27.6% | 241,503 | -5.9% | 0.00% | – |
| Q2 2023 | $249,150 | +42.6% | 256,592 | +28.4% | 0.00% | – |
| Q1 2023 | $174,675 | +91834.2% | 199,858 | 0.0% | 0.00% | – |
| Q4 2022 | $190 | -99.9% | 199,858 | +5.0% | 0.00% | – |
| Q3 2022 | $209,000 | -9.1% | 190,418 | 0.0% | 0.00% | – |
| Q2 2022 | $230,000 | -69.8% | 190,418 | -46.3% | 0.00% | – |
| Q1 2022 | $762,000 | -81.6% | 354,787 | +1.5% | 0.00% | – |
| Q4 2021 | $4,149,000 | -14.7% | 349,576 | +11.5% | 0.00% | -100.0% |
| Q3 2021 | $4,864,000 | -6.6% | 313,655 | +22.8% | 0.00% | 0.0% |
| Q2 2021 | $5,205,000 | +28.1% | 255,348 | +42.9% | 0.00% | 0.0% |
| Q1 2021 | $4,064,000 | -17.7% | 178,752 | +0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,940,000 | – | 178,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |